Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ret Proto-Oncogene Antikörper (pTyr1062) (AbBy Fluor® 594)

Der Kaninchen Polyklonal Anti-Ret Proto-Oncogene-Antikörper wurde für WB, IF (cc) und IF (p) validiert. Er ist geeignet, Ret Proto-Oncogene in Proben von Human zu detektieren.
Produktnummer ABIN2805907

Kurzübersicht für Ret Proto-Oncogene Antikörper (pTyr1062) (AbBy Fluor® 594) (ABIN2805907)

Target

Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
Ret Proto-Oncogene (RET)

Reaktivität

  • 204
  • 96
  • 73
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 177
  • 76
  • 2
  • 2
  • 1
  • 1
Kaninchen

Klonalität

  • 174
  • 85
Polyklonal

Konjugat

  • 103
  • 18
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
Dieser Ret Proto-Oncogene Antikörper ist konjugiert mit AbBy Fluor® 594

Applikation

  • 171
  • 86
  • 64
  • 64
  • 54
  • 27
  • 19
  • 17
  • 15
  • 12
  • 10
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Bindungsspezifität

    • 56
    • 19
    • 18
    • 15
    • 15
    • 15
    • 11
    • 9
    • 9
    • 8
    • 8
    • 8
    • 7
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr1062

    Homologie

    Human,Mouse,Rat,Dog,Cow,Rabbit

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic phosphopeptide derived from human Ret around the phosphorylation site of Tyr1062

    Isotyp

    IgG
  • Applikationshinweise

    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    Ret Proto-Oncogene (RET)

    Andere Bezeichnung

    Ret

    Hintergrund

    Synonyms: C ret, Cadherin family member 12, Cadherin related family member 16, CDHF 12, CDHF12, CDHR16, ELKS Fusion gene, HSCR 1, HSCR1, Hydroxyaryl protein kinase, MEN2A, MEN2B, MTC 1, MTC1, Multiple endocrine neoplasia and medullary thyroid carcinoma 1, Oncogene RET, Proto oncogene tyrosine protein kinase receptor ret, Proto-oncogene c-Ret, Proto-oncogene tyrosine-protein kinase receptor ret, PTC, RET, RET ELE1, Ret Proto oncogene, RET transforming sequence, RET_HUMAN, RET51, RET9, tyrosine-protein kinase receptor ret.

    Background: The CD4 antigen is highly expressed on human T helper cells and thymocytes, and at lower levels on monocytes and dendritic cells. This integral membrane glycoprotein of approximately 58 kDa contains four external domains (D1 to D4) that show homology to members of the immunoglobulin (Ig) superfamily. It is responsible for the recognition of the MHC class II antigen. The CD4 antibody recognizes most thymocytes and about 65 % of peripheral blood T cells.

    Gen-ID

    5979

    Pathways

    RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Sie sind hier:
Chat with us!